# Bruker to acquire ELITechGroup for €870M

Bruker Corporation entered into a definitive share purchase agreement to acquire ELITechGroup for €870 million in cash. The transaction is expected to close in the second quarter of 2024.

- Type: Acquisition
- Announced: 2024-02-28
- Value: $940.0M (870.0M EUR)
- Status: announced
- Products: molecular diagnostic systems (InGenius, BeGenius), PCR diagnostic assays
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Bruker Corporation](https://endata.com/companies/19227.md) (acquirer)
- [ELITechGroup](https://endata.com/companies/75902.md) (target)

## Sources

- [ir.bruker.com](https://ir.bruker.com/press-releases/press-release-details/2024/Bruker-Announces-Share-Purchase-Agreement-to-Acquire-Molecular-Diagnostics-Innovator-ELITechGroup/default.aspx), 2024-02-28: "Bruker Corporation announced today that it has entered into a definitive share purchase agreement with TecFin S.à r.l., a controlled affiliate of PAI Partners, to acquire ELITechGroup, for €870 million in cash."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.